IsoRay (ISR) Stock Active After Co. Files 10-Q

Go back to IsoRay (ISR) Stock Active After Co. Files 10-Q

IsoRay (ISR) Posts Q3 Loss of 5c/Share

May 16, 2014 9:45 AM EDT

IsoRay (NYSE: ISR) reported Q3 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $1.13 million versus the consensus estimate of $1.13 million.

IsoRay Chairman and CEO Dwight Babcock commented, "The recent publication of the first peer reviewed article showing positive results using Cs-131 in the treatment of... More